Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology.

Gyberg V, De Bacquer D, De Backer G, Jennings C, Kotseva K, Mellbin L, Schnell O, Tuomilehto J, Wood D, Rydén L, Amouyel P, Bruthans J, Conde AC, Cifkova R, Deckers JW, De Sutter J, Dilic M, Dolzhenko M, Erglis A, Fras Z, Gaita D, Gotcheva N, Goudevenos J, Heuschmann P, Laucevicius A, Lehto S, Lovic D, Miličić D, Moore D, Nicolaides E, Oganov R, Pająk A, Pogosova N, Reiner Z, Stagmo M, Störk S, Tokgözoğlu L, Vulic D; EUROASPIRE Investigators.

Cardiovasc Diabetol. 2015 Oct 1;14:133. doi: 10.1186/s12933-015-0296-y.

2.

Effects of medical therapies on retinopathy progression in type 2 diabetes.

ACCORD Study Group; ACCORD Eye Study Group, Chew EY, Ambrosius WT, Davis MD, Danis RP, Gangaputra S, Greven CM, Hubbard L, Esser BA, Lovato JF, Perdue LH, Goff DC Jr, Cushman WC, Ginsberg HN, Elam MB, Genuth S, Gerstein HC, Schubart U, Fine LJ.

N Engl J Med. 2010 Jul 15;363(3):233-44. doi: 10.1056/NEJMoa1001288. Epub 2010 Jun 29. Erratum in: N Engl J Med. 2011 Jan 13;364(2):190. N Engl J Med. 2012 Dec 20;367(25):2458.

3.

Variation in the net benefit of aggressive cardiovascular risk factor control across the US population of patients with diabetes mellitus.

Timbie JW, Hayward RA, Vijan S.

Arch Intern Med. 2010 Jun 28;170(12):1037-44. doi: 10.1001/archinternmed.2010.150.

4.

Coronary artery calcium in relation to initiation and continuation of cardiovascular preventive medications: The Multi-Ethnic Study of Atherosclerosis (MESA).

Nasir K, McClelland RL, Blumenthal RS, Goff DC Jr, Hoffmann U, Psaty BM, Greenland P, Kronmal RA, Budoff MJ.

Circ Cardiovasc Qual Outcomes. 2010 May;3(3):228-35. doi: 10.1161/CIRCOUTCOMES.109.893396. Epub 2010 Apr 6.

5.

Diminishing efficacy of combination therapy, response-heterogeneity, and treatment intolerance limit the attainability of tight risk factor control in patients with diabetes.

Timbie JW, Hayward RA, Vijan S.

Health Serv Res. 2010 Apr;45(2):437-56. doi: 10.1111/j.1475-6773.2009.01075.x. Epub 2010 Jan 8.

Supplemental Content

Loading ...
Support Center